The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Orrick, Herrington & Sutcliffe LLP

Orrick, Herrington & Sutcliffe (Europe) LLP focuses on serving companies in the technology, energy, infrastructure and financial sectors.

The firm: Founded in San Francisco 150 years ago, Orrick is a leading global law firm with a particular focus on serving companies in the technology, energy, infrastructure and financial sectors. The firm is recognised worldwide for delivering the highest quality, commercially oriented legal advice.

Orrick in London is an established and highly regarded presence in the world’s leading financial centres. Clients include leading banks and other financial institutions, FTSE 100 companies, energy and infrastructure companies, private equity funds, professional services, real estate and venture-backed technology companies. The firm’s integrated team of transactional, regulatory and litigation lawyers, qualified in English and US law, is experienced in meeting the needs of clients. It offers expertise in banking and corporate finance, venture capital, cross-border M&A, IPOs and other corporate fundraising, joint ventures and strategic alliances, competition, employment, real estate, restructuring, private equity, emerging markets, tax, cybersecurity and data privacy, litigation, investigations and international arbitration.

Much of the firm’s work in London involves cross-border transactions, disputes and projects that span Europe, the Middle East, Africa, Asia and the Americas. The London office has extensive experience in emerging markets – particularly in Eastern Europe and Africa. With a ‘one-firm’ culture, Orrick’s lawyers collaborate as part of integrated teams to meet the global needs of clients.

Types of work undertaken:

Technology: Orrick is one of only a handful of firms in London that offers technology-focused clients the experience and contacts within one of the leading Silicon Valley-originated technology practices. The team includes US-qualified and dual-qualified lawyers, some of whom have practised in Silicon Valley. It advises technology companies at all stages in the corporate life cycle, from startups to global multinational companies. It also represents leading venture capital and private equity firms. In addition to completing numerous venture financings, it successfully advises on M&A exits and IPOs. The team represents technology companies in complex merger control investigations before the European Commission. It also advises on issues at the nexus of antitrust and intellectual property.

Energy and infrastructure: the energy team brings broad experience in M&A, trading, project development, financing and cross-border projects. Its experience covers every fuel source and technology across oil and gas, power and renewable energy, and it acts for all market segments including independent power producers, governments, sponsors, trading houses, private equity funds, emerging companies, investors, utilities, developers, lenders and underwriters. In oil and gas, Orrick acts on upstream, midstream and downstream trading projects, working for companies, lenders and governments. It has also recently advised on the acquisition or disposal of in excess of 300MW of renewable energy projects.

Finance: the London finance team represents leading credit providers and borrowers (including private equity sponsors) in a wide range of international/cross-border and UK transactions, including leveraged and acquisition financings, greenfield and brownfield real estate and project financings, and high-yield and structured financings. It has an active practice representing alternative credit providers, and advises private credit and direct lending providers, investment funds, hedge funds, real estate investors and other alternative lenders on acquisition financings, single-asset project and real estate financings, asset-based loans, mezzanine financings, unitranche facilities and venture capital loans.

Restructuring: the restructuring team acts for alternative credit providers, hedge funds and special situations teams of investment banks to execute investment strategies that may involve loan-to-own techniques, pre-pack enforcements and debt-to-equity swaps either outside court or involving a court process throughout Europe.

Real estate: the London real estate team provides comprehensive support for investors based in the UK and internationally. It has extensive experience in shopping centres and retail, and has been involved in some of the largest transactions in the UK.

Other offices: Beijing, Brussels, Düsseldorf, Geneva, Hong Kong, Houston, Los Angeles, Milan, Moscow, Munich, New York, Orange County, Paris, Portland, Rome, Sacramento, San Francisco, Seattle, Shanghai, Silicon Valley, Taipei, Tokyo, Washington DC, Wheeling.

Above material supplied by Orrick, Herrington & Sutcliffe LLP.

Legal Developments in Switzerland

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • Bär & Karrer Continues to Grow Finance and Sports Practice with Two New Partners

    Bär & Karrer is pleased to announce that it further strengthens its Financing and Sports practices with new partners Lukas Roesler and Dr. Jan Kleiner, both of whom have worked with the firm previously.
  • Bär & Karrer Advises Novartis and Alcon on the Spin-off of Alcon

    Today, Novartis AG completed the spin-off of the Alcon eye care devices business, and Alcon Inc. debuted as independent publicly traded company. The Alcon shares were successfully listed on the SIX Swiss Exchange Ltd. and the New York Stock Exchange. They are also included in the Swiss Market Index (SMI), which comprises the 20 largest Swiss listed stocks.
  • Bär & Karrer Advises Primeo Energie and CSA Energie-Infrastructure Schweiz in Aquisition from Elét

    Primeo Energie, EOS Holding SA (EOS) and Électricité de France (EDF) have entered into a share purchase agreement relating to the purchase by Primeo Energie and EOS of the 25% interest held by EDF in Alpiq Holding SA. The purchase by Primeo Eergie and EOS will be financed through mandatory exchangeable loan agreements made by CSA Energie-Infrastruktur Schweiz (CSA) as lender, the biggest investment pool for Swiss energy infrastructure with 135 Swiss pension funds acting as investors. At maturity the mandatory exchangeable loan agreements will be converted into shares in Alpiq. Primeo Energie and EOS thereby pave the way for a Swiss shareholder structure of Alpiq.
  • Bär & Karrer Awarded Most Innovative Swiss Law Firm of the Year at the IFLR Europe Awards

    Bär & Karrer was awarded „Most innovative law firm of the year - Switzerland", the national award for Switzerland given in the IFLR European Awards. The most innovative law firm of the year award recognizes Bär & Karrer as the Swiss law firm with the best track record in 2018 giving advice on the most innovative cross-border deals covering all award practice areas. It is already the third prize of this kind in period of six years awarded to Bär & Karrer.
  • Bär & Karrer Advises DSV on Public Exchange Offer for Panalpina

    On 1 April 2019, DSV A/S, Hedehusene, Denmark and Panalpina Welttransport (Holding) AG, Zurich, Switzerland, have entered into an agreement on the terms and conditions of a combination by way of a public exchange offer by DSV for all publicly held registered shares of Panalpina for approximately CHF 4.6 billion. The board of directors of Panalpina has resolved to support the public exchange offer by DSV and to recommend the acceptance of DSV's public exchange offer to its shareholders.
  • Bär & Karrer Advises Lonza on the Entering into a Strategic Joint Venture with Chr. Hansen for Deve

    On 2 April 2019, Lonza, a leading pharma contract manufacturing company, and Chr. Hansen, a leading global bioscience company, announced that they have signed an agreement to establish a 50/50 joint venture to pioneer the live biotherapeutic products (LBPs) industry and position themselves as the leading contract development and manufacturing partner (CDMO) for biotech and pharma customers. The joint venture brings together best-in-class, complementary capabilities and will be the first CDMO globally to provide a full supply chain that offers manufacturing of bacteria strains for therapeutic use. The joint venture will be a 50/50 controlled legal entity that will operate from its headquarters in Basel (CH) and have production facilities in Denmark and Switzerland. A phased investment of approximately EUR 90 million will be deployed over three years to build cGMP-compliant pharma production capabilities. The joint venture will upgrade existing facilities in Hørsholm (DK) and equip new facilities in Basel (CH) to serve pre-clinical to phase II projects. Further facilities for phase III and commercial manufacturing will be developed as the pipeline matures. The joint venture is expected to be largely self-funding after the production set-up has been established.
  • Bär & Karrer Advises Computacenter in the Acquisition of PathWorks

    Computacenter Group, a leading European IT service provider listed on the London Stock Exchange, acquired PathWorks, a well-established hardware reseller in the Swiss market.
  • Bär & Karrer Advises Addtech in the Acquisition of a Majority in Omni Ray

    Addtech Group, a leading Swedish publicly listed technology trading group, acquired a majority stake in Omni Ray AG, a well-established Swiss trading company and service provider for automation solutions, mainly focused on industrial applications, infrastructure, transportation and medical industry. By this transaction, Addtech aims at strengthening its position in the European automation market.
  • Bär & Karrer Partner Paolo Bottini Wins the Client Choice Award 2019 by Lexology

    Bär & Karrer is pleased to announce that partner Paolo Bottini has been recognized by Lexology and the International Law Office (ILO) as the Client Choice Winner 2019 in the Corporate Tax category in Switzerland.
  • Bär & Karrer Advises CEVA Logistics in Connection with the Strengthening of the Strategic Partnersh

    On 11 October 2018, the board of directors of CEVA Logistics AG announced that the Danish transport and logistic company DSV submitted a non-binding letter of interest with an indicative offer price of CHF 27.75 per CEVA share and that the board of directors of CEVA came to the conclusion that the offer was not in the best interest of the company and its shareholders. This was in particular because at that point in time, CEVA was already in discussions regarding an intensified cooperation with its main shareholder CMA CGM S.A., which shall exploit the full potential of CEVA.